Literature DB >> 15128946

Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion.

Mark S Sundrud1, Victor J Torres, Derya Unutmaz, Timothy L Cover.   

Abstract

Recent evidence indicates that the secreted Helicobacter pylori vacuolating toxin (VacA) inhibits the activation of T cells. VacA blocks IL-2 secretion in transformed T cell lines by suppressing the activation of nuclear factor of activated T cells (NFAT). In this study, we investigated the effects of VacA on primary human CD4(+) T cells. VacA inhibited the proliferation of primary human T cells activated through the T cell receptor (TCR) and CD28. VacA-treated Jurkat T cells secreted markedly diminished levels of IL-2 compared with untreated cells, whereas VacA-treated primary human T cells continued to secrete high levels of IL-2. Further experiments indicated that the VacA-induced inhibition of primary human T cell proliferation was not attributable to VacA effects on NFAT activation or IL-2 secretion. We show here that VacA suppresses IL-2-induced cell-cycle progression and proliferation of primary human T cells without affecting IL-2-dependent survival. Through the analysis of a panel of mutant VacA proteins, we demonstrate that VacA-mediated inhibition of T cell proliferation requires an intact N-terminal hydrophobic region necessary for the formation of anion-selective membrane channels. Remarkably, we demonstrate that one of these mutant VacA proteins [VacA-Delta(6-27)] abrogates the immunosuppressive actions of wild-type VacA in a dominant-negative fashion. We suggest that VacA may inhibit the clonal expansion of T cells that have already been activated by H. pylori antigens, thereby allowing H. pylori to evade the adaptive immune response and establish chronic infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128946      PMCID: PMC419674          DOI: 10.1073/pnas.0401528101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Involvement of syntaxin 7 in human gastric epithelial cell vacuolation induced by the Helicobacter pylori-produced cytotoxin VacA.

Authors:  Junko Suzuki; Hirohide Ohnishi; Akihiro Wada; Toshiya Hirayama; Hideki Ohno; Namiki Ueda; Hiroshi Yasuda; Taroh Iiri; Yoh Wada; Masamitsu Futai; Hirosato Mashima
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

2.  Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation.

Authors:  David C Willhite; Timothy L Cover; Steven R Blanke
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

3.  Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor.

Authors:  S Fiering; J P Northrop; G P Nolan; P S Mattila; G R Crabtree; L A Herzenberg
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

4.  Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA).

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

5.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.

Authors:  D J Price; J R Grove; V Calvo; J Avruch; B E Bierer
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

6.  Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Authors:  J Nourse; E Firpo; W M Flanagan; S Coats; K Polyak; M H Lee; J Massague; G R Crabtree; J M Roberts
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

7.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.

Authors:  J Chung; C J Kuo; G R Crabtree; J Blenis
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

8.  Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells.

Authors:  Masaaki Nakayama; Miyuki Kimura; Akihiro Wada; Kinnosuke Yahiro; Ken-ichi Ogushi; Takuro Niidome; Akihiro Fujikawa; Daisuke Shirasaka; Nobuo Aoyama; Hisao Kurazono; Masaharu Noda; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2003-11-20       Impact factor: 5.157

9.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

10.  The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

Authors:  Marianna Boncristiano; Silvia Rossi Paccani; Silvia Barone; Cristina Ulivieri; Laura Patrussi; Dag Ilver; Amedeo Amedei; Mario Milco D'Elios; John L Telford; Cosima T Baldari
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  98 in total

1.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells.

Authors:  Ayako Matsumoto; Hajime Isomoto; Masaaki Nakayama; Junzo Hisatsune; Yoshito Nishi; Yujiro Nakashima; Kayoko Matsushima; Hisao Kurazono; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

3.  Surreptitious manipulation of the human host by Helicobacter pylori.

Authors:  Dawn A Israel; Richard M Peek
Journal:  Gut Microbes       Date:  2010-03

4.  Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.

Authors:  Xisheng Wang; Peter F Barnes; Karen M Dobos-Elder; James C Townsend; Yoon-tae Chung; Homayoun Shams; Stephen E Weis; Buka Samten
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance.

Authors:  Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 8.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

Review 9.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

10.  Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin.

Authors:  Holly M Scott Algood; Victor J Torres; Derya Unutmaz; Timothy L Cover
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.